New technique could revolutionize stem-cell transplants
Montreal researchers are taking part in what could become a breakthrough in stem cell transplants, by leading the first transplant of a mismatched donor.
Montreal researchers are taking part in what could become a breakthrough in stem cell transplants, by leading the first transplant of a mismatched donor.
StemCyte, Inc. concluded an exclusive license and commercialization agreement with Academia Sinica, the National Laboratory of Taiwan, for certain proprietary methods and Intellectual Property related to the treatment of Chronic Stroke with stem cells.
Stemline Therapeutics, Inc., a private clinical stage biopharmaceutical company and leading developer of oncology compounds directed to cancer stem cells, today announced that The University of Texas M.D.
A novel technology involving use of stem cells, developed by Hebrew University of Jerusalem researchers, has been applied to provide better and rapid healing for patients suffering from complicated bone fractures.
Stem cells have been found to protect and repair the lungs of newborn rats, according to a study led by University of Alberta researchers. The research team hopes that the new findings might have significant implications for premature babies with …
Conservationists work constantly through habitat protection and other means to save these and other endangered species. And now they are adding a new technology to their list of possible solutions to extinction — stem cells. Scientists at the San …
Health officials say that Canada’s stem cell and bone marrow banks need more donors from the country’s ethnic communities.
The firm was founded a year ago and seeks to treat blood flow issues.
A procedure that uses a person’s own stem cells to carry out a breast augmentation is now available in the UK. Lucy Mead, a 23-year-old sales adviser from Middlesex, told the Daily Mail that she had the procedure to boost her breasts from their …
Stem cell scientists have modified a human embryonic stem cell (hESC) line to glow red when the stem cells become red blood cells. The modified hESC line, ErythRED, represents a major step forward to the eventual aim of generating mature, fully functional red blood cells from human embryonic stem cells.